Il sito dell'Oncologia
dell'Azienda Ospedaliera Cannizzaro di Catania

Dr Giuseppe L. Banna

Born in Catania, Italy on June 25th 1974

Work at the Oncologia, A.O. Cannizzaro, Via Messina 829, 95126 Catania, Italy

Tel: +39 3921385347 
Email: gbanna @ yahoo.com


- 2002, Fellowship, University of Padova, Oncology
- 1999-2002, Fellow at the Division of Oncology and Bone Marrow Transplantation Unit, University Hospital of Padova, Padova, Italy
- 1998-1999, Attendance, University of Catania and University of Padova - Qualification to the professional practice, University of Catania, - M.D.
- 1998, University of Catania, Medicine, 1998.
- 1996-1998, Attendance, Oncology Unit, San Luigi Hospital of Catania.

Other Qualifications:

- 2001, English language: PET certificate.


- 2010-present, Consultant at the Medical Oncology, Cannizzaro Hospital – Catania, Italy
- 2006-2010, Consultant at the Division of Medical Oncology, Vittorio Emanuele University Hospital – Catania, Italy - Director Dr Calogero Buscarino
- 2004-2006, Consultant at the Department of Oncology and Hematology, Istituto Clinico Humanitas –- Rozzano, Milano, Italy - Director Dr Armando Santoro
- 2003-2004, Consultant at the Unit of Oncology and Bone Marrow Transplantation, University Hospital of Padova – Padova, Italy - Director Dr Silvio Monfardini

Publications on PubMed:

- Banna GL, Lipari H, Nicolosi M, Basile A, Fraggetta F, Vaglica M, Marletta F, Urso OE, Ippolito M, Terminella A, Saita S. A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer. Med Oncol. 2013 Jun;30(2):533.
- Gebbia V, Bellavia M, Banna GL, Russo P, Ferraù F, Tralongo P, Borsellino N. Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2013 Jan 9.
- Di Maio M, Bria E, Banna GL, Puglisi F, Garassino MC, Lorusso D, Perrone F. Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors. Anticancer Drugs. 2013 Feb; 24(2):99-111.
- Basile A, Masala S, Banna G, Cotta E, Cavalli M, Fiumara P, Di Raimondo F, Mundo E, Scavone G, Granata A, Carrafiello G, Tsetis D. Intrasomatic injection of corticosteroid followed by vertebroplasty increases early pain relief rather than vertebroplasty alone in vertebral bone neoplasms: preliminary experience. Skeletal Radiol. 2012 Apr;41(4):459-64. Epub 2011 Nov 16
- Paratore S, Banna GL, D'Arrigo M, Saita S, Iemmolo R, Lucenti L, Bellia D, Lipari H, - Buscarino C, Cunsolo R, Cavallaro S. CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases. Cancer Biomark. 2011-2012;10(2):79-89.
- Simonelli M, Rosti G, Banna GL, Pedrazzoli P; on behalf of the Italian Germ cell cancer Group (IGG) and Gruppo Italiano Trapianto Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO). Intensified chemotherapy with stem-cell rescue in germ-cell tumors. Ann Oncol. 2011 Sep 23. [Epub ahead of print]
- Novello S, Milella M, Tiseo M, Banna G, Cortinovis D, Di Maio M, Garassino M, Maione P, Martelli O, Vavalà T, Bria E. (2011) Maintenance therapy in NSCLC: why? To whom? Which agent? J Exp Clin Cancer Res. 2011 May 6;30:50.
- Cavallaro S, Paratore S, de Snoo F, Salomone E, Villari L, Buscarino C, Ferraù F, Banna G, Furci M, Strazzanti A, Cunsolo R, Pezzino S, Gangi S, Basile F. (2011) Genomic analysis: Toward a new approach in breast cancer management. Crit Rev Oncol Hematol. 2011 Apr 19.
- Banna GL, Di Maio M, Follador A, Collovà E, Menis J, Novello S, Bria E; on behalf of ISA Co-Authors. (2010) Italian Survey on Adjuvant treatment of non-small cell lung cancer (ISA). Lung Cancer. Dec 6. [Epub ahead of print]
- International Prognostic Factors Study Group, Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. (2010). Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol, 28, 4906-11
- Banna G.L., Collovà E., Gebbia V., Lipari H., Giuffrida P., Cavallaro S., Condorelli R, Buscarino C., Tralongo P., Ferraù F. (2010) Anticancer oral therapy: emerging related issues. Cancer Treatment Reviews, 36, 595-605
- Donach M., Yu Y., Artioli G., Banna G., Feng W., Bast R.C., Zhang Z, Nicoletto M.O. (2010) Combined use of biomarkers improves negative predictive value in women at high risk for developing ovarian cancer. Tumour Biol, 31(3), 209-15.
- Simonelli, M., Banna, G.L., Santoro, A. (2009) Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy. Tumori, 95, 243-7.
- Basile, A., Banna, G., Saita, S., Coppolino, F., Patti, M.T. (2009) Is a 1-cm margin from major vessels adequate for radiofrequency ablation of pulmonary neoplasms? Ann Thorac Surg, 88, 351-2.
- Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L.M. & De Maria, R. (2008). Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res, 14, 8205-12.
- Guarneri, V., Frassoldati, A., Ficarra, G., Puglisi, F., Andreetta, C., Michelotti, A., Cresti, N., Boni, C., Bisagni, G., Berardi, R., Battelli, N., Santoro, A., Banna, G., Bottini, A., Di Blasio, B., Maiorana, A., Piacentini, F., Giovannelli, S., Jovic, G. & Conte, P. (2008). Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. Breast Cancer Res Treat, 110, 127-34.
- Basile, A., Giuliano, G., Scuderi, V., Motta, S., Crisafi, R., Coppolino, F., Mundo, E., Banna, G., Di Raimondo, F. & Patti, M.T. (2008). Cementoplasty in the management of painful extraspinal bone metastases: our experience. Radiol Med, 113, 1018-28.
- Todisco, E., Castagna, L., Sarina, B., Mazza, R., Anastasia, A., Balzarotti, M., Banna, G., Tirelli, U., Soligo, D. & Santoro, A. (2007). Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion. Eur J Haematol, 78, 322-9.
- Banna, G.L., Bettio, D., Scorsetti, M., Navarria, P., Simonelli, M., Rodriguez Baena, R., Aimar, E., Gaetani, P., Colombo, P., Rognone, F. & Santoro, A. (2007). Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme. J Neurooncol, 81, 323-5.
- Banna, G.L., Simonelli, M. & Santoro, A. (2007). High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review. Curr Stem Cell Res Ther, 2, 65-82.
- Banna, G.L. & Santoro, A. (2006). Trastuzumab in breast cancer. N Engl J Med, 354, 640-4; author reply 640-4.
- Banna, G.L., Aversa, S.M., Crivellari, G., Ghiotto, C., Chiarion-Sileni, V. & Monfardini, S. (2006). Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer. Br J Cancer, 94, 1550-2.
- Banna, G.L., De Giorgi, U., Ferrari, B., Castagna, L., Alloisio, M., Marangolo, M., Rosti, G. & Santoro, A. (2006). Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Biol Blood Marrow Transplant, 12, 1085-91
- Aversa, S.M., Cattelan, A.M., Salvagno, L., Crivellari, G., Banna, G., Trevenzoli, M., Chiarion-Sileni, V. & Monfardini, S. (2005). Treatments of AIDS-related Kaposi's sarcoma. Crit Rev Oncol Hematol, 53, 253-65.
- Banna, G.L., Aversa, S.M., Cattelan, A.M., Crivellari, G. & Monfardini, S. (2004). Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy. Scand J Infect Dis, 36, 155-7.
- Banna, G.L., Aversa, S., Sileni, V.C., Favaretto, A., Ghiotto, C. & Monfardini, S. (2004). Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens. Crit Rev Oncol Hematol, 51, 171-89.
- Aversa, S.M., Salvagno, L., Soraru, M., Mazzarotto, R., Boso, C., Gaion, F., Chiarion-Sileni, V., De Franchis, G., Favaretto, A.G., Crivellari, G., Banna, G.L., Sotti, G. & Monfardini, S. (2004). Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease. Acta Haematol, 112, 141-7.
- Nicoletto, M.O., Donach, M., De Nicolo, A., Artioli, G., Banna, G. & Monfardini, S. (2001). BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev, 27, 295-304.
- Menin, C., Banna, G.L., De Salvo, G., Lazzarotto, V., De Nicolo, A., Agata, S., Montagna, M., Sordi, G., Nicoletto, O., Chieco-Bianchi, L. & D'Andrea, E. (2001). Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett, 168, 31-6.

Experience on Clinical Trials

- More than 20 clinical trials followed as sub-investigator according to the requirements of GCP protocols
- More than 5 clinical trials as Principal Investigator according to the requirements of GCP protocols

Nessun commento:

Posta un commento